Feasibility of Bright Light Therapy on Fatigue, Sleep and Circadian Activity Rhythms in Lung Cancer Survivors
The purpose of this study is to determine the feasibility of a morning bright light therapy intervention for fatigue, sleep disturbances, and circadian activity rhythms in lung cancer survivors.
Checked against the public recordLast updated May 1, 2025 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Device Feasibility
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- State University of New York at Buffalo
- Interventions being studied
- Device: Morning bright light therapy; Device: Dim light
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Stage I-III Non-small cell lung cancer survivors * Must be at \>6-weeks and \< 3 years post-surgical resection * Must have diagnosis fatigue and/or sleep disturbances Exclusion Criteria: * Individuals clinically unstable. * Mania, Bipolar disease or seizure disorder * Macular degeneration or glaucoma. * Currently receiving chemotherapy or radiation.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- SUNY University at BuffaloBuffalo, New York
Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 1, 2025. Always confirm current availability with the study team.